Subsquamous intestinal metaplasia after ablation of Barrett's esophagus: Frequency and importance

Current Opinion in Gastroenterology

Volumn 29, Issue 4, 2013, Pages 454-459

  Mashimo, Hiroshi ^a  

^a HARVARD MEDICAL SCHOOL   (United States)

Author keywords

Barrett's esophagus; buried metaplasia; optical coherence tomography; subsquamous intestinal metaplasia

Indexed keywords

OMEPRAZOLE;

ABLATION THERAPY; BARRETT ESOPHAGUS; CANCER GROWTH; CONFOCAL MICROSCOPY; ENDOSCOPIC BIOPSY; ENDOSCOPIC THERAPY; ENDOSCOPY; EPITHELIAL MESENCHYMAL TRANSITION; ERADICATION THERAPY; ESOPHAGEAL ADENOCARCINOMA; ESOPHAGUS BIOPSY; ESOPHAGUS RESECTION; FOLLOW UP; HUMAN; INTESTINE METAPLASIA; LAMINA PROPRIA; LOWER ESOPHAGUS SPHINCTER; NONHUMAN; OPTICAL COHERENCE TOMOGRAPHY; PREVALENCE; REVIEW; SQUAMOUS EPITHELIUM; SUBSQUAMOUS INTESTINAL METAPLASIA;

ADENOCARCINOMA; BARRETT ESOPHAGUS; CATHETER ABLATION; DISEASE PROGRESSION; ESOPHAGEAL NEOPLASMS; ESOPHAGOSCOPY; ESOPHAGUS; HUMANS; METAPLASIA; PRECANCEROUS CONDITIONS; TOMOGRAPHY, OPTICAL COHERENCE;

EID: 84879908293     PISSN: 02671379     EISSN: 15317056     Source Type: Journal    
DOI: 10.1097/MOG.0b013e3283622796     Document Type: Review

References (38)

1. Shaheen NJ, Sharma P, Overholt BF, et al. Radiofrequency ablation in Barrett's esophagus with dysplasia. N Engl J Med 2009; 360:2277-2288.
2. Ganz RA, Overholt BF, Sharma VK, et al. Circumferential ablation ofBarrett's esophagus that contains high-grade dysplasia: a U.S. Multicenter Registry. Gastrointest Endosc 2008; 68:35-40.
3. Bennett C, Vakil N, Bergman J, et al. Consensus statements for management of Barrett's dysplasia and early-stage esophageal adenocarcinoma, based on a Delphi process. Gastroenterology 2012; 143:336-346.
4. Shaheen NJ, Overholt BF, Sampliner RE, et al. Durability of radiofrequency ablation in Barrett's esophagus with dysplasia. Gastroenterology 2011; 141:460-468.
5. Orman ES, Kim HP, Bulsiewicz WJ, et al. Intestinal metaplasia recurs infrequently in patients successfully treated for Barrett's esophagus with radio frequency ablation. Am J Gastroenterol 2013; 108:187-195.
6. Dunbar KB, Spechler SJ. The risk of lymph-node metastases in patients with high-grade dysplasia or intramucosal carcinoma in Barrett's esophagus: a systematic review. Am J Gastroenterol 2012; 107:850-862.
7. Elmunzer BJ. How common are lymph node metastases in patients with Barrett's esophagus complicated by high-grade dysplasia or intramucosal cancer? Gastroenterology 2013; 144:242-243.
8. Kelty CJ, Gough MD, Van Wyk Q, et al. Barrett's oesophagus: intestinal metaplasia is not essential for cancer risk. Scand J Gastroenterol 2007; 42:1271-1274.
9. Sun Q, Huang Q, Feng AN, et al. Columnar-lined esophagus in Chinese patients with proximal gastric carcinomas. J Dig Dis 2013; 14:22-28.
10. Hornick JL, Blount PL, Sanchez CA, et al. Biologic properties of columnar epithelium underneath reepithelialized squamous mucosa in Barrett's eso-phagus. Am J Surg Pathol 2005; 29:372-380.
11. Sharma P, Morales TG, Bhattacharyya A, et al. Squamous islands in Barrett's esophagus: what lies underneath? Am J Gastroenterol 1998; 93:332-335.
12. Reid BJ, Blount PL, Feng Z, Levine DS. Optimizing endoscopic biopsy detection of early cancers in Barrett's high-grade dysplasia. Am J Gastro-enterol 2000; 95:3089-3096.
13. Mashimo H, Fujimoto J. Reply to Pouw. Endoscopy 2010; 42:180-181.
14. Adler DC, Zhou C, Tsai TH, et al. Three-dimensional optical coherence tomography of Barrett's esophagus and buried glands beneath neosquamous epithelium following radiofrequency ablation. Endoscopy 2009; 41:773-776.
15. Shaheen NJ, Peery AF, Overholt BF, et al. Biopsy depth after radiofrequency ablation of dysplastic Barrett's esophagus. Gastrointest Endosc 2010; 72:490-496; e1.
16. Gray NA, Odze RD, Spechler SJ. Buried metaplasiaafterendoscopicablation of Barrett's esophagus: a systematic review. Am J Gastroenterol 2011; 106:1899-1908.
17. Gupta N, Mathur SC, Dumot JA, et al. Adequacy of esophageal squamous mucosa specimens obtained during endoscopy: are standard biopsies sufficient for postablation surveillance in Barrett's esophagus? Gastrointest Endosc 2012; 75:11-18.
18. Titi M, Overhiser A, Ulusarac O, et al. Development of subsquamous high-grade dysplasia and adenocarcinoma after successful radiofrequency ablation of Barrett's esophagus. Gastroenterology 2012; 143:564-566.
19. Chennat J, Ross AS, Konda VJ, et al. Advanced pathology undersquamous epithelium on initial EMR specimens in patients with Barrett's esophagus and high-grade dysplasia or intramucosal carcinoma: implications for sur-veillance and endotherapy management. Gastrointest Endosc 2009; 70:417-421.
20. Bronner MP, Overholt BF, Taylor SL, et al. Squamous overgrowth is not a safety concern for photodynamic therapy for Barrett's esophagus with high-grade dysplasia. Gastroenterology 2009; 136:56-64.
21. Ban S, Mino M, Nishioka NS, et al. Histopathologic aspects of photodynamic therapy for dysplasia and early adenocarcinoma arising in Barrett's esopha-gus. Am J Surg Pathol 2004; 28:1466-1473.
22. Mino-Kenudson M, Ban S, Ohana M, et al. Buried dysplasia and early adenocarcinoma arising in barrett esophagus after porfimer-photodynamic therapy. Am J Surg Pathol 2007; 31:403-409.
23. Shaheen NJ, Greenwald BD, Peery AF, et al. Safety and efficacy of endo-scopic spray cryotherapy for Barrett's esophagus with high-grade dysplasia. Gastrointest Endosc 2010; 71:680-685.
24. Cobb MJ, Hwang JH, Upton MP, et al. Imaging of subsquamous Barrett's epithelium with ultrahigh-resolution optical coherence tomography: a histo-logic correlation study. Gastrointest Endosc 2010; 71:223-230.
25. Zhou C, Tsai TH, Lee HC, et al. Characterization of buried glands before and after radiofrequency ablation by using 3-dimensional optical coherence tomography (with videos). Gastrointest Endosc 2012; 76:32-40.
26. Tsai TH, Zhou C, Tao YK, et al. Structural markers observed with endoscopic 3-dimensional optical coherence tomography correlating with Barrett's esophagus radiofrequency ablation treatment response (with videos). Gastrointest Endosc 2012; 76:1104-1112.
27. Gora MJ, Sauk JS, Carruth RW, et al. Tethered capsule endomicroscopy enables lessinvasiveimaging of gastro intestinaltract micro structure. Nat Med 2013; 19:238-240.
28. Spechler SJ, Sharma P, Souza RF, et al. American Gastroenterological Association technical review on the management of Barrett's esophagus. Gastroenterology 2011; 140:e18-e52.
29. Souza RF, Schwartz RE, Mashimo H. Esophageal stem cells and 3D-cell culture models. Ann N Y Acad Sci 2011; 1232:316-322.
30. Kalabis J, Oyama K, Okawa T, et al. A subpopulation of mouse esophageal basal cells has properties of stem cells with the capacity for self-renewal and lineage specification. J Clin Invest 2008; 118:3860-3869.
31. Becker L, Huang Q, Mashimo H. Immunostaining of Lgr5, an intestinal stem cell marker, in normal and premalignant human gastrointestinal tissue. Scientific World Journal 2008; 8:1168-1176.
32. Becker L, Huang Q, Mashimo H. Lgr5, an intestinal stem cell marker, is abnormally expressed in Barrett's esophagus and esophageal adenocarci-noma. Dis Esophagus 2010; 23:168-174.
33. Wong GS, Habibollahi P, Heidari P, et al. Cellular origin of Barrett's esophagus: controversy and therapeutic implications. Gastroenterology 2012;142:1424-1430.
34. Tomizawa Y, Wu TT, Wang KK. Epithelial mesenchymal transition and cancer stem cells in esophageal adenocarcinoma originating from Barrett's esophagus. Oncol Lett 2012; 3:1059-1063.
35. Hornick JL, Mino-Kenudson M, Lauwers GY, et al. Buried Barrett's epithelium following photodynamic therapy shows reduced crypt proliferation and absenceof DNA contentabnormalities. Am J Gastroenterol 2008; 103:38-47.
36. Krishnan K, Komanduri S, Cluley J, et al. Radio frequency ablation for dysplasia in Barrett's esophagus restores beta-catenin activation within esophageal progenitor cells. Dig Dis Sci 2012; 57:294-302.
37. Terry NG, Zhu Y, Rinehart MT, et al. Detection of dysplasia in Barrett's esophagus with in vivo depth-resolved nuclear morphology measurements. Gastroenterology 2011; 140:42-50.
38. Wong GS, Habibollahi P, Heidari P, et al. Optical imaging of periostin enables early endoscopic detection and characterization of esophageal cancer in mice. Gastroenterology 2013; 144:294-297.